Literature DB >> 18471087

Identification of duchenne muscular dystrophy female carriers by fluorescence in situ hybridization and RT-PCR.

Ana Claudia Velázquez-Wong1, César Hernández-Huerta, Areli Márquez-Calixto, Fidel Omar Hernández-Aguilar, Maricela Rodríguez-Cruz, Fabio Salamanca-Gómez, Ramón Coral-Vázquez.   

Abstract

Duchenne muscular dystrophy (DMD) is an X-linked recessive neuromuscular disorder caused by mutations in the dystrophin DMD gene located at Xp21.1 region. Up to 65% of the patients present dystrophin gene deletions. Mothers of DMD patients have a two-thirds chance of carrying a dystrophin mutation. The female carrier will transmit the disease gene to half of her sons and half of her daughters. As the recurrence risk for the disease is extremely high, it is very important to detect carrier status among female relatives of the patients to bring an adequate genetic counseling. In this work, results from two methods to identify female carriers are presented. One method is a multicolor fluorescence in situ hybridization (FISH) assay, and the other is reverse transcriptase-polymerase chain reaction (RT-PCR). We showed that FISH is an efficient, sensitive method that brings confident results to detect DMD female carriers as compared to RT-PCR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18471087     DOI: 10.1089/gte.2007.0081

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  2 in total

1.  Analysis of dystrophin gene in Iranian Duchenne and Becker muscular dystrophies patients and identification of a novel mutation.

Authors:  Gholam Reza Zamani; Fatemeh Karami; Mahshid Mehdizadeh; Abolfazl Movafagh; Yalda Nilipour; Mahdi Zamani
Journal:  Neurol Sci       Date:  2015-06-17       Impact factor: 3.307

2.  Gene diagnosis for nine Chinese patients with DMD/BMD by multiplex ligation-dependent probe amplification and prenatal diagnosis for one of them.

Authors:  Yupeng Wu; Gengxin Yin; Keqin Fu; De Wu; Qian Zhai; Huarong Du; Zhongjun Huang; Yuhua Niu
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.